Lack of pur-alpha alters postnatal brain development and causes megalencephaly

Human Molecular Genetics

Volumn 21, Issue 3, 2012, Pages 473-484

  Hokkanen, Suvi ^a   Feldmann, Heidi M ^a   Ding, Haiyan ^a   Jung, Christian K E ^a   Bojarski, Lukasz ^b   ller, Ingrid Renner Mü ^a   Schüller, Ulrich ^a   Kretzschmar, Hans ^a   Wolf, Eckhard ^a   Herms, Jochen ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b INTERNATIONAL INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN 2; PUR ALPHA PROTEIN; RNA BINDING PROTEIN; SINGLE STRANDED DNA; UNCLASSIFIED DRUG;

ALEXANDER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; BRAIN GROWTH; BRAIN SIZE; BRAIN WEIGHT; CELL DENSITY; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CEREBELLUM; CONTROLLED STUDY; DENDRITE; HIPPOCAMPUS; HISTOPATHOLOGY; KNOCKOUT MOUSE; MITOSIS; MOUSE; NERVE FIBER; NEURAL STEM CELL; NEUROFILAMENT; NONHUMAN; PHENOTYPE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PURKINJE CELL; STRATUM LACUNOSUM MOLECULARE; TREMOR;

ANIMALS; AXONS; BRAIN; BRAIN CHEMISTRY; CELL PROLIFERATION; CEREBELLUM; CEREBRUM; DNA-BINDING PROTEINS; HIPPOCAMPUS; HYPERTROPHY; MICE; MICE, KNOCKOUT; MICROTUBULE-ASSOCIATED PROTEINS; NERVE TISSUE PROTEINS; NEUROFILAMENT PROTEINS; PHOSPHORYLATION;

MUS;

EID: 84856097593     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr476     Document Type: Article

References (54)

1. Bergemann, A.D. and Johnson, E.M. (1992) The HeLa Pur factor binds single-stranded DNA at a specific element conserved in gene flanking regions and origins of DNA replication. Mol. Cell. Biol., 12, 1257-1265.
2. Bergemann, A.D., Ma, Z.W. and Johnson, E.M. (1992) Sequence of cDNA comprising the human pur gene and sequence-specific single-stranded-DNA-binding properties of the encoded protein. Mol. Cell. Biol., 12, 5673-5682.
3. Gallia, G.L., Johnson, E.M. and Khalili, K. (2000) Puralpha: a multifunctional single-stranded DNA- and RNA-binding protein. Nucleic Acids Res., 28, 3197-3205.
4. Johnson, E.M. (2003) The Pur protein family: clues to function from recent studies on cancer and AIDS. Anticancer Res., 23, 2093-2100.
5. Johnson, E.M., Kinoshita, Y., Weinreb, D.B., Wortman, M.J., Simon, R., Khalili, K., Winckler, B. and Gordon, J. (2006) Role of Pur alpha in targeting mRNA to sites of translation in hippocampal neuronal dendrites. J. Neurosci. Res., 83, 929-943.
6. Stacey, D.W., Hitomi, M., Kanovsky, M., Gan, L. and Johnson, E.M. (1999) Cell cycle arrest and morphological alterations following microinjection of NIH3T3 cells with Pur alpha. Oncogene, 18, 4254-4261.
7. Barr, S.M. and Johnson, E.M. (2001) Ras-induced colony formation and anchorage-independent growth inhibited by elevated expression of Puralpha in NIH3T3 cells. J. Cell. Biochem., 81, 621-638.
8. Darbinian, N., Gallia, G.L., King, J., Del Valle, L., Johnson, E.M. and Khalili, K. (2001) Growth inhibition of glioblastoma cells by human Pur(alpha). J. Cell. Physiol., 189, 334-340.
9. Lezon-Geyda, K., Najfeld, V. and Johnson, E.M. (2001) Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia. Leukemia, 15, 954-962.
10. Haas, S., Gordon, J. and Khalili, K. (1993) A developmentally regulated DNA-binding protein from mouse brain stimulates myelin basic protein gene expression. Mol. Cell. Biol., 13, 3103-3112.
11. Tretiakova, A., Gallia, G.L., Shcherbik, N., Jameson, B., Johnson, E.M., Amini, S. and Khalili, K. (1998) Association of Puralpha with RNAs homologous to 7 SL determines its binding ability to the myelin basic protein promoter DNA sequence. J. Biol. Chem., 273, 22241-22247.
12. Khalili, K., Del Valle, L., Muralidharan, V., Gault, W.J., Darbinian, N., Otte, J., Meier, E., Johnson, E.M., Daniel, D.C., Kinoshita, Y. et al. (2003) Puralpha is essential for postnatal brain development and developmentally coupled cellular proliferation as revealed by genetic inactivation in the mouse. Mol. Cell. Biol., 23, 6857-6875.
13. Hagerman, R.J., Leehey, M., Heinrichs, W., Tassone, F., Wilson, R., Hills, J., Grigsby, J., Gage, B. and Hagerman, P.J. (2001) Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology, 57, 127-130.
14. Jacquemont, S., Hagerman, R.J., Leehey, M., Grigsby, J., Zhang, L., Brunberg, J.A., Greco, C., Des Portes, V., Jardini, T., Levine, R. et al. (2003) Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am. J. Hum. Genet., 72, 869-878.
15. Jin, P., Duan, R., Qurashi, A., Qin, Y., Tian, D., Rosser, T.C., Liu, H., Feng, Y. and Warren, S.T. (2007) Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome. Neuron, 55, 556-564.
16. Li, Y., Koike, K., Ohashi, S., Funakoshi, T., Tadano, M., Kobayashi, S., Anzai, K., Shibata, N. and Kobayashi, M. (2001) Pur alpha protein implicated in dendritic RNA transport interacts with ribosomes in neuronal cytoplasm. Biol. Pharm. Bull., 24, 231-235.
17. Taupin, P. (2007) BrdU immunohistochemistry for studying adult neurogenesis: paradigms, pitfalls, limitations, and validation. Brain Res. Rev., 53, 198-214.
18. Lopez, F., Belloc, F., Lacombe, F., Dumain, P., Reiffers, J., Bernard, P. and Boisseau, M.R. (1991) Modalities of synthesis of Ki67 antigen during the stimulation of lymphocytes. Cytometry, 12, 42-49.
19. Zacchetti, A., van Garderen, E., Teske, E., Nederbragt, H., Dierendonck, J.H. and Rutteman, G.R. (2003) Validation of the use of proliferation markers in canine neoplastic and non-neoplastic tissues: comparison of KI-67 and proliferating cell nuclear antigen (PCNA) expression versus in vivo bromodeoxyuridine labelling by immunohistochemistry. APMIS, 111, 430-438.
20. Kurki, P., Vanderlaan, M., Dolbeare, F., Gray, J. and Tan, E.M. (1986) Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle. Exp. Cell Res., 166, 209-219.
21. Hendzel, M.J., Wei, Y., Mancini, M.A., Van Hooser, A., Ranalli, T., Brinkley, B.R., Bazett-Jones, D.P. and Allis, C.D. (1997) Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma, 106, 348-360.
22. Blichenberg, A., Schwanke, B., Rehbein, M., Garner, C.C., Richter, D. and Kindler, S. (1999) Identification of a cis-acting dendritic targeting element in MAP2 mRNAs. J. Neurosci., 19, 8818-8829.
23. Huang, Y.S., Carson, J.H., Barbarese, E. and Richter, J.D. (2003) Facilitation of dendritic mRNA transport by CPEB. Genes Dev., 17, 638-653.
24. Nixon, R.A. and Shea, T.B. (1992) Dynamics of neuronal intermediate filaments: a developmental perspective. Cell Motil. Cytoskeleton, 22, 81-91.
25. Pant, H.C. and Veeranna (1995) Neurofilament phosphorylation. Biochem. Cell Biol., 73, 575-592.
26. Bu, B., Li, J., Davies, P. and Vincent, I. (2002) Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model. J. Neurosci., 22, 6515-6525.
27. Julien, J.P. and Mushynski, W.E. (1982) Multiple phosphorylation sites in mammalian neurofilament polypeptides. J. Biol. Chem., 257, 10467-10470.
28. Goldstein, M.E., Sternberger, L.A. and Sternberger, N.H. (1983) Microheterogeneity ('neurotypy') of neurofilament proteins. Proc. Natl Acad. Sci. USA, 80, 3101-3105.
29. Johnson, E.M., Chen, P.L., Krachmarov, C.P., Barr, S.M., Kanovsky, M., Ma, Z.W. and Lee, W.H. (1995) Association of human Pur alpha with the retinoblastoma protein, Rb, regulates binding to the single-stranded DNA Pur alpha recognition element. J. Biol. Chem., 270, 24352-24360.
30. Darbinian, N., Gallia, G.L., Kundu, M., Shcherbik, N., Tretiakova, A., Giordano, A. and Khalili, K. (1999) Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1. Oncogene, 18, 6398-6402.
31. Darbinian, N., White, M.K. and Khalili, K. (2006) Regulation of the Pur-alpha promoter by E2F-1. J. Cell Biochem., 99, 1052-1063.
32. Safak, M., Gallia, G.L. and Khalili, K. (1999) Reciprocal interaction between two cellular proteins, Puralpha and YB-1, modulates transcriptional activity of JCVCY in glial cells. Mol. Cell. Biol., 19, 2712-2723.
33. Tretiakova, A., Steplewski, A., Johnson, E.M., Khalili, K. and Amini, S. (1999) Regulation of myelin basic protein gene transcription by Sp1 and Puralpha: evidence for association of Sp1 and Puralpha in brain. J. Cell Physiol., 181, 160-168.
34. Liu, H., Barr, S.M., Chu, C., Kohtz, D.S., Kinoshita, Y. and Johnson, E.M. (2005) Functional interaction of Puralpha with the Cdk2 moiety of cyclin A/Cdk2. Biochem. Biophys. Res. Commun., 328, 851-857.
35. Bruchova, H., Borovanova, T., Klamova, H. and Brdicka, R. (2002) Gene expression profiling in chronic myeloid leukemia patients treated with hydroxyurea. Leuk. Lymphoma, 43, 1289-1295.
36. Wang, L.G., Johnson, E.M., Kinoshita, Y., Babb, J.S., Buckley, M.T., Liebes, L.F., Melamed, J., Liu, X.M., Kurek, R., Ossowski, L. et al. (2008) Androgen receptor overexpression in prostate cancer linked to Pur alpha loss from a novel repressor complex. Cancer Res., 68, 2678-2688.
37. Kleiman, R., Banker, G. and Steward, O. (1990) Differential subcellular localization of particular mRNAs in hippocampal neurons in culture. Neuron, 5, 821-830.
38. Crino, P.B. and Eberwine, J. (1996) Molecular characterization of the dendritic growth cone: regulated mRNA transport and local protein synthesis. Neuron, 17, 1173-1187.
39. Bassell, G. and Singer, R.H. (1997) mRNA and cytoskeletal filaments. Curr. Opin. Cell Biol., 9, 109-115.
40. Shafit-Zagardo, B. and Kalcheva, N. (1998) Making sense of the multiple MAP-2 transcripts and their role in the neuron. Mol. Neurobiol., 16, 149-162.
41. Tiedge, H., Fremeau, R.T. Jr, Weinstock, P.H., Arancio, O. and Brosius, J. (1991) Dendritic location of neural BC1 RNA. Proc. Natl Acad. Sci. USA, 88, 2093-2097.
42. Wang, H. and Tiedge, H. (2004) Translational control at the synapse. Neuroscientist, 10, 456-466.
43. Wang, H., Iacoangeli, A., Lin, D., Williams, K., Denman, R.B., Hellen, C.U. and Tiedge, H. (2005) Dendritic BC1 RNA in translational control mechanisms. J. Cell Biol., 171, 811-821.
44. Kobayashi, S., Agui, K., Kamo, S., Li, Y. and Anzai, K. (2000) Neural BC1 RNA associates with pur alpha, a single-stranded DNA and RNA binding protein, which is involved in the transcription of the BC1 RNA gene. Biochem. Biophys. Res. Commun., 277, 341-347.
45. Ohashi, S., Kobayashi, S., Omori, A., Ohara, S., Omae, A., Muramatsu, T., Li, Y. and Anzai, K. (2000) The single-stranded DNA- and RNA-binding proteins pur alpha and pur beta link BC1 RNA to microtubules through binding to the dendrite-targeting RNA motifs. J. Neurochem., 75, 1781-1790.
46. Tiedge, H., Bloom, F.E. and Richter, D. (1999) RNA, whither goest thou? Science, 283, 186-187.
47. Brosius, J. and Tiedge, H. (2001) Neuronal BC1 RNA: intracellular transport and activity-dependent modulation. Results Probl. Cell Differ., 34, 129-138.
48. Muslimov, I.A., Titmus, M., Koenig, E. and Tiedge, H. (2002) Transport of neuronal BC1 RNA in Mauthner axons. J Neurosci., 22, 4293-4301.
49. Cristofanilli, M., Iacoangeli, A., Muslimov, I.A. and Tiedge, H. (2006) Neuronal BC1 RNA: microtubule-dependent dendritic delivery. J. Mol. Biol., 356, 1118-1123.
50. Skryabin, B.V., Sukonina, V., Jordan, U., Lewejohann, L., Sachser, N., Muslimov, I., Tiedge, H. and Brosius, J. (2003) Neuronal untranslated BC1 RNA: targeted gene elimination in mice. Mol. Cell Biol., 23, 6435-6441.
51. Bassell, G.J. andWarren, S.T. (2008) FragileX syndrome: loss of localmRNA regulation alters synaptic development and function. Neuron, 60, 201-214.
52. Ohashi, S., Koike, K., Omori, A., Ichinose, S., Ohara, S., Kobayashi, S., Sato, T.A. and Anzai, K. (2002) Identification of mRNA/protein (mRNP) complexes containing Puralpha, mStaufen, fragile X protein, and myosin Va and their association with rough endoplasmic reticulum equipped with a kinesin motor. J. Biol. Chem., 277, 37804-37810.
53. Leehey, M.A. (2009) Fragile X-associated tremor/ataxia syndrome: clinical phenotype, diagnosis, and treatment. J. Investig. Med., 57, 830-836.
54. Chiu, S., Wegelin, J.A., Blank, J., Jenkins, M., Day, J., Hessl, D., Tassone, F. and Hagerman, R. (2007) Early acceleration of head circumference in children with fragile x syndrome and autism. J. Dev. Behav. Pediatr., 28, 31-35.